Updated Jul 16, 2026
Patel Samir Rashmikant is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $344K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2024-12-30 | AKTX | Akari Therapeutics Plc | A — Grant or award | 400.0K | $0.00 | $200 |
| 2024-12-30 | AKTX | Akari Therapeutics Plc | A — Grant or award | 3.20M | $0.00 | $2K |
| 2024-12-27 | AKTX | Akari Therapeutics Plc | A — Grant or award | 7.50M | $0.00 | $4K |
| 2024-12-26 | AKTX | Akari Therapeutics Plc | A — Grant or award | 1.40M | $0.00 | $700 |
| 2024-12-03 | AKTX | Akari Therapeutics Plc | A — Grant or award | 419.29M | $0.00 | $503K |
| 2024-11-18 | AKTX | Akari Therapeutics Plc | A — Grant or award | 1404.62M | — |
Patel Samir Rashmikant is a corporate insider — currently tracked as Director, 10% Owner. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 4 open-market purchases ($344K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Patel Samir Rashmikant profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.